Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?
- PMID: 8968945
- DOI: 10.1007/BF02737061
Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?
Abstract
To understand and intervene in neuronal cell death, intensive investigations have been directed at the discovery of intracellular and extracellular factors that provide natural neuroprotection. This goal has fundamental importance for both rational strategies for the treatment of neurodegenerative diseases and also the delineation of molecular mechanisms that regulate nervous system differentiation and growth. We have discovered a potential interface among these fields of research with activity-dependent neurotrophic factor (ADNF), a protein containing sequence homologies to intracellular stress proteins that is found in the extracellular milieu of astroglial cells incubated with the neuropeptide vasoactive intestinal peptide (VIP). Femtomolar concentrations of ADNF and a short peptide sequence derived from it (a peptidergic active site) protected neurons from death associated with a broad range of toxins, including those related to Alzheimer's disease, the human immunodeficiency virus, excito-toxicity, and electrical blockade. Because the activity of the protein was mimicked by a short peptide fragment, this peptide is now proposed as a lead compound for drug development against neurodegeneration.
Similar articles
-
VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide.Ann N Y Acad Sci. 1998 Dec 11;865:207-12. doi: 10.1111/j.1749-6632.1998.tb11180.x. Ann N Y Acad Sci. 1998. PMID: 9928014 Review.
-
Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism.Ann N Y Acad Sci. 1999;897:17-26. doi: 10.1111/j.1749-6632.1999.tb07875.x. Ann N Y Acad Sci. 1999. PMID: 10676432 Review.
-
Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity.Brain Res Dev Brain Res. 1997 Apr 18;99(2):167-75. doi: 10.1016/s0165-3806(96)00215-5. Brain Res Dev Brain Res. 1997. PMID: 9125470
-
A new concept in the pharmacology of neuroprotection.J Mol Neurosci. 2000 Feb-Apr;14(1-2):61-8. doi: 10.1385/JMN:14:1-2:061. J Mol Neurosci. 2000. PMID: 10854037 Review.
-
A femtomolar-acting neuroprotective peptide.J Clin Invest. 1996 May 15;97(10):2299-307. doi: 10.1172/JCI118672. J Clin Invest. 1996. PMID: 8636410 Free PMC article.
Cited by
-
NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).BMC Neurosci. 2008 Dec 10;9 Suppl 3(Suppl 3):S3. doi: 10.1186/1471-2202-9-S3-S3. BMC Neurosci. 2008. PMID: 19091000 Free PMC article.
-
VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury.J Mol Neurosci. 2000 Dec;15(3):147-54. doi: 10.1385/JMN:15:3:147. J Mol Neurosci. 2000. PMID: 11303779
-
Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides.J Mol Neurosci. 1997 Dec;9(3):211-22. doi: 10.1007/BF02800503. J Mol Neurosci. 1997. PMID: 9481622
-
Tubulin is the target binding site for NAP-related peptides: ADNF-9, D-NAP, and D-SAL.J Mol Neurosci. 2006;28(3):303-7. doi: 10.1385/JMN:28:3:303. J Mol Neurosci. 2006. PMID: 16691018
-
Microtubule stabilising peptides rescue tau phenotypes in-vivo.Sci Rep. 2016 Dec 2;6:38224. doi: 10.1038/srep38224. Sci Rep. 2016. PMID: 27910888 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources